Indication: It is mainly used to treat edema diseases and can also be used as an adjuvant treatment for refractory hypokalemia.

Indication: 1. Edema diseases: It is used in combination with other diuretics to treat edema diseases such as congestive edema, ascites caused by liver cirrhosis, and renal edema. The purpose is to correct the increased secondary aldosterone secretion associated with the above diseases and counteract the potassium excretion effect of other diuretics. It is also used to treat idiopathic edema. 2. Hypertension: It is used as an auxiliary drug for the treatment of hypertension. 3. Primary aldosteronism: Spironolactone can be used for the diagnosis and treatment of this disease. 4. Prevention of hypokalemia: It is used in combination with thiazide diuretics to enhance the diuretic effect and prevent hypokalemia.

Indication: This product is mainly used for various bleeding caused by acute or chronic, localized or systemic primary hyperfibrinolysis. This product is generally not used for secondary hyperfibrinolytic state caused by disseminated intravascular coagulation before heparinization. This product is also suitable for: 1. Traumatic or surgical bleeding in organs rich in plasminogen activators such as the prostate, urethra, lungs, brain, uterus, adrenal glands, and thyroid glands. 2. Used as an antagonist of tissue plasminogen activator (t-PA), streptokinase, and urokinase. 3. Fibrinolytic bleeding caused by artificial abortion, early placental abruption, stillbirth, and amniotic fluid embolism. 4. Excessive menstruation, hyphema, and severe epistaxis caused by pathologically increased local fibrinolysis in the uterine cavity. 5. Mild bleeding caused by rupture of central aneurysm, such as subarachnoid hemorrhage and intracranial aneurysm bleeding, this product is better than other antifibrinolytic drugs in stopping bleeding, but attention must be paid to the risk of concurrent cerebral edema or cerebral infarction. As for patients with severe conditions and surgical indications, this product can only be used as an auxiliary drug. 6. Treatment of hereditary angioedema can reduce the frequency and severity of its attacks. 7. This drug can be used in combination with hemophilia patients with active bleeding. 8. Prevent or reduce bleeding after tooth extraction or oral surgery in hemophilia patients with factor VIII or factor IX deficiency. 9. Severe bleeding caused by excessive thrombolysis.

Indication: 1. This product is mainly used for various bleeding caused by acute or chronic, localized or systemic primary hyperfibrinolysis. Secondary hyperfibrinolytic state caused by disseminated intravascular coagulation is generally not used before heparinization; 2. It is used for trauma or surgical bleeding in organs rich in plasminogen activators such as the prostate, urethra, lungs, brain, uterus, adrenal glands, and thyroid glands; 3. It is used as an antagonist of tissue plasminogen activator (t-PA), streptokinase, and urokinase; 4. It is used for fibrinolytic bleeding caused by artificial abortion, early placental abruption, stillbirth, and amniotic fluid embolism, as well as menorrhagia caused by pathological local increased fibrinolysis in the uterine cavity; 5. It is used for This product is superior to other antifibrinolytics in stopping bleeding caused by central nervous system diseases, such as subarachnoid hemorrhage and intracranial aneurysm bleeding. However, attention must be paid to the risk of concurrent cerebral edema or cerebral infarction. For patients with severe conditions and surgical indications, this product can only be used as an auxiliary drug; 6. It is used to treat hereditary angioedema to reduce the frequency and severity of attacks; 7. This drug can be used in combination with hemophilia patients with active bleeding; 8. It is used to prevent or reduce bleeding after tooth extraction or oral surgery in hemophilia patients with factor VIII or factor IX deficiency.

Indication: It is used for ischemic cerebrovascular disease (such as cerebral thrombosis, cerebral embolism), thrombophlebitis, central retinitis, edema caused by increased vascular permeability, etc.